About BDR Pharmaceuticals Internationals
BDR Pharmaceuticals Internationals is a company based in Mumbai (India) founded in 2003 by Dharmesh Shah.. BDR Pharmaceuticals Internationals has raised $88.16 million across 1 funding round from investors including BKT Tires, State Bank of India and Multiples Alternate Asset Management. The company has 1,864 employees as of October 31, 2024. BDR Pharmaceuticals Internationals offers products and services including API, Formulations, and Pellets. BDR Pharmaceuticals Internationals operates in a competitive market with competitors including Almac Group, Indoco Remedies, Concord Biotech, Aurobindo Pharma and Asymchem, among others.
- Headquarter Mumbai, India
- Employees 1864 as on 31 Oct, 2024
- Founders Dharmesh Shah
- Stage Soonicorn
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Bdr Pharmaceuticals Internationals Pvt. Ltd.
-
Annual Revenue
$134.65 M (USD)8as on Mar 31, 2024
-
Net Profit
$28.89 M (USD)16as on Mar 31, 2024
-
EBITDA
$43.81 M (USD)16as on Mar 31, 2024
-
Total Equity Funding
$88.16 M (USD)
in 1 rounds
-
Latest Funding Round
$88.16 M (USD), Private Equity Round
Jan 24, 2022
-
Investors
BKT Tires
& 9 more
-
Employee Count
1864
as on Oct 31, 2024
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of BDR Pharmaceuticals Internationals
BDR Pharmaceuticals Internationals offers a comprehensive portfolio of products and services, including API, Formulations, and Pellets. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Manufactures niche APIs with advanced facilities for quality compliance.
Develops and markets various dosage forms for affordable healthcare.
Creates sustained-release pellets using innovative technologies.
Unlock access to complete
Unlock access to complete
Funding Insights of BDR Pharmaceuticals Internationals
BDR Pharmaceuticals Internationals has successfully raised a total of $88.16M through 1 strategic funding round. The most recent funding activity was a Private Equity Round round of $88.16 million completed in January 2022. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 1
- Last Round Private Equity Round — $88.2M
-
First Round
First Round
(24 Jan 2022)
- Investors Count 10
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jan, 2022 | Amount | Private Equity Round - BDR Pharmaceuticals Internationals | Valuation | Multiples Alternate Asset Management |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in BDR Pharmaceuticals Internationals
BDR Pharmaceuticals Internationals has secured backing from 10 investors, including venture fund, angel, and institutional investors. Prominent investors backing the company include BKT Tires, State Bank of India and Multiples Alternate Asset Management. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Investment partnerships, entrepreneur support, and profit-focused services in finance.
|
Founded Year | Domain | Location | |
|
Schools and pre-schools are established in India and abroad.
|
Founded Year | Domain | Location | |
|
Venture capital firm focused on early-stage companies
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by BDR Pharmaceuticals Internationals
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - BDR Pharmaceuticals Internationals
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Bdr Pharmaceuticals Internationals Comparisons
Competitors of BDR Pharmaceuticals Internationals
BDR Pharmaceuticals Internationals operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Almac Group, Indoco Remedies, Concord Biotech, Aurobindo Pharma and Asymchem, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Integrated CDMO services for biopharma R&D and manufacturing are offered.
|
|
| domain | founded_year | HQ Location |
APIs manufacturing and formulation services are provided in therapeutic segments.
|
|
| domain | founded_year | HQ Location |
APIs and enzymes are manufactured through fermentation by the CDMO.
|
|
| domain | founded_year | HQ Location |
Generic biocatalytic solutions are provided for pharmaceutical applications.
|
|
| domain | founded_year | HQ Location |
APIs and peptides are developed and manufactured by Asymchem.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Bdr Pharmaceuticals Internationals
Frequently Asked Questions about BDR Pharmaceuticals Internationals
When was BDR Pharmaceuticals Internationals founded?
BDR Pharmaceuticals Internationals was founded in 2003 and raised its 1st funding round 19 years after it was founded.
Where is BDR Pharmaceuticals Internationals located?
BDR Pharmaceuticals Internationals is headquartered in Mumbai, India. It is registered at Mumbai, Maharashtra, India.
Is BDR Pharmaceuticals Internationals a funded company?
BDR Pharmaceuticals Internationals is a funded company, having raised a total of $88.16M across 1 funding round to date. The company's 1st funding round was a Private Equity Round of $88.16M, raised on Jan 24, 2022.
How many employees does BDR Pharmaceuticals Internationals have?
As of Oct 31, 2024, the latest employee count at BDR Pharmaceuticals Internationals is 1,864.
What is the annual revenue of BDR Pharmaceuticals Internationals?
Annual revenue of BDR Pharmaceuticals Internationals is $134.65M as on Mar 31, 2024.
What does BDR Pharmaceuticals Internationals do?
BDR Pharmaceuticals Internationals was established in 2003 in Mumbai, India. Active pharmaceutical ingredients are developed and produced, alongside finished formulations. New drug delivery systems and generic versions are created for therapeutic segments including oncology, critical care, gynecology, respiratory conditions, antidiabetics, neurology, and additional categories. Manufacturing sites are certified under WHO-GMP standards.
Who are the top competitors of BDR Pharmaceuticals Internationals?
BDR Pharmaceuticals Internationals's top competitors include Concord Biotech, Almac Group and Indoco Remedies.
What products or services does BDR Pharmaceuticals Internationals offer?
BDR Pharmaceuticals Internationals offers API, Formulations, and Pellets.
Who are BDR Pharmaceuticals Internationals's investors?
BDR Pharmaceuticals Internationals has 10 investors. Key investors include BKT Tires, State Bank of India, Multiples Alternate Asset Management, Kama Holdings, and Nishant Agarwal.
What is BDR Pharmaceuticals Internationals's valuation?
The valuation of BDR Pharmaceuticals Internationals is $950.33M as of Jan 2022.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.